In addition, Zhou et al. showed a higher expression of HOTAIR and a lower PTEN expression in samples of patients with relapsed and refractory AML and doxorubicin-resistant cell lines compared to control samples. This evidence concerns the gene PTEN and acute myeloid leukemia.